GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » Price-to-Funds-From-Operations

Oxurion NV (FRA:TG40) Price-to-Funds-From-Operations : (As of Dec. 14, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Oxurion NV Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Oxurion NV Business Description

Industry
Traded in Other Exchanges
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.